| pubmed-article:19120877 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19120877 | lifeskim:mentions | umls-concept:C0019196 | lld:lifeskim |
| pubmed-article:19120877 | lifeskim:mentions | umls-concept:C0733511 | lld:lifeskim |
| pubmed-article:19120877 | lifeskim:mentions | umls-concept:C0439661 | lld:lifeskim |
| pubmed-article:19120877 | lifeskim:mentions | umls-concept:C1522326 | lld:lifeskim |
| pubmed-article:19120877 | lifeskim:mentions | umls-concept:C1292734 | lld:lifeskim |
| pubmed-article:19120877 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:19120877 | pubmed:dateCreated | 2009-1-5 | lld:pubmed |
| pubmed-article:19120877 | pubmed:abstractText | Hepatitis C treatment uptake in Australia is low. We describe the rate of acute hepatitis C treatment in the Australian state of Victoria by linking the centralized passive notifications system for hepatitis C with the Australian Trial in Acute Hepatitis C (ATAHC), a nationwide clinical trial aimed at providing people with newly acquired hepatitis C with 24 weeks' pegylated interferon monotherapy. | lld:pubmed |
| pubmed-article:19120877 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19120877 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19120877 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19120877 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19120877 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19120877 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19120877 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19120877 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:19120877 | pubmed:issn | 1440-1746 | lld:pubmed |
| pubmed-article:19120877 | pubmed:author | pubmed-author:MehtaP APA | lld:pubmed |
| pubmed-article:19120877 | pubmed:author | pubmed-author:HellardMargar... | lld:pubmed |
| pubmed-article:19120877 | pubmed:author | pubmed-author:WalshNickN | lld:pubmed |
| pubmed-article:19120877 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19120877 | pubmed:volume | 23 | lld:pubmed |
| pubmed-article:19120877 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19120877 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19120877 | pubmed:pagination | 1891-4 | lld:pubmed |
| pubmed-article:19120877 | pubmed:meshHeading | pubmed-meshheading:19120877... | lld:pubmed |
| pubmed-article:19120877 | pubmed:meshHeading | pubmed-meshheading:19120877... | lld:pubmed |
| pubmed-article:19120877 | pubmed:meshHeading | pubmed-meshheading:19120877... | lld:pubmed |
| pubmed-article:19120877 | pubmed:meshHeading | pubmed-meshheading:19120877... | lld:pubmed |
| pubmed-article:19120877 | pubmed:meshHeading | pubmed-meshheading:19120877... | lld:pubmed |
| pubmed-article:19120877 | pubmed:meshHeading | pubmed-meshheading:19120877... | lld:pubmed |
| pubmed-article:19120877 | pubmed:meshHeading | pubmed-meshheading:19120877... | lld:pubmed |
| pubmed-article:19120877 | pubmed:meshHeading | pubmed-meshheading:19120877... | lld:pubmed |
| pubmed-article:19120877 | pubmed:meshHeading | pubmed-meshheading:19120877... | lld:pubmed |
| pubmed-article:19120877 | pubmed:meshHeading | pubmed-meshheading:19120877... | lld:pubmed |
| pubmed-article:19120877 | pubmed:meshHeading | pubmed-meshheading:19120877... | lld:pubmed |
| pubmed-article:19120877 | pubmed:meshHeading | pubmed-meshheading:19120877... | lld:pubmed |
| pubmed-article:19120877 | pubmed:meshHeading | pubmed-meshheading:19120877... | lld:pubmed |
| pubmed-article:19120877 | pubmed:meshHeading | pubmed-meshheading:19120877... | lld:pubmed |
| pubmed-article:19120877 | pubmed:meshHeading | pubmed-meshheading:19120877... | lld:pubmed |
| pubmed-article:19120877 | pubmed:meshHeading | pubmed-meshheading:19120877... | lld:pubmed |
| pubmed-article:19120877 | pubmed:meshHeading | pubmed-meshheading:19120877... | lld:pubmed |
| pubmed-article:19120877 | pubmed:meshHeading | pubmed-meshheading:19120877... | lld:pubmed |
| pubmed-article:19120877 | pubmed:meshHeading | pubmed-meshheading:19120877... | lld:pubmed |
| pubmed-article:19120877 | pubmed:meshHeading | pubmed-meshheading:19120877... | lld:pubmed |
| pubmed-article:19120877 | pubmed:meshHeading | pubmed-meshheading:19120877... | lld:pubmed |
| pubmed-article:19120877 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:19120877 | pubmed:articleTitle | Using a surveillance system to identify and treat newly acquired hepatitis C infection. | lld:pubmed |
| pubmed-article:19120877 | pubmed:affiliation | Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Melbourne, Australia. nicktropical@yahoo.com | lld:pubmed |
| pubmed-article:19120877 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19120877 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:19120877 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19120877 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19120877 | lld:pubmed |
